These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37321454)

  • 1. Safety and immunogenicity of the live-attenuated varicella vaccine in pediatric solid organ transplant recipients: A systematic review and meta-analysis.
    Piché-Renaud PP; Yue Lee E; Ji C; Qing Huang JY; Uleryk E; Teoh CW; Morris SK; Top KA; Upton JEM; Vyas MV; Allen UD
    Am J Transplant; 2023 Nov; 23(11):1757-1770. PubMed ID: 37321454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients.
    Feldman AG; Beaty BL; Ferrolino JA; Maron G; Weidner HK; Ali SA; Bitterfeld L; Boulware MA; Campbell KM; Carr E; Chapman S; Chang YC; Cunningham R; Dallas RH; Dantuluri KL; Domenick BN; Ebel NH; Elisofon S; Fawaz R; Foca M; Gans HA; Gopalareddy VV; Gu C; Gupta NA; Harmann K; Hollenbeck J; Huppler AR; Jaramillo C; Kasi N; Kerkar N; Lerret S; Lobritto SJ; Lopez MJ; Marini E; Mavis A; Mehra S; Moats L; Mohandas S; Munoz FM; Mysore KR; Onsan C; Ovchinsky N; Perkins K; Postma S; Pratscher L; Rand EB; Rowe RK; Schultz D; Sear K; Sell ML; Sharma T; Stoll J; Vang M; Villarin D; Weaver C; Wood P; Woodford-Berry O; Yanni G; Danziger-Isakov LA
    JAMA Netw Open; 2023 Oct; 6(10):e2337602. PubMed ID: 37824141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
    Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
    Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Kawano Y; Suzuki M; Kawada J; Kimura H; Kamei H; Ohnishi Y; Ono Y; Uchida H; Ogura Y; Ito Y
    Vaccine; 2015 Mar; 33(12):1440-5. PubMed ID: 25665961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of measles, mumps, rubella and varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs.
    Danerseau AM; Robinson JL
    World J Pediatr; 2008 Nov; 4(4):254-8. PubMed ID: 19104888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; McIntyre P
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001833. PubMed ID: 18646079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; Heywood A; McIntyre P
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001833. PubMed ID: 24954057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parent and healthcare provider views of live varicella vaccination of pediatric solid organ transplant recipients.
    Condran B; Kervin M; Burton C; Blydt-Hansen TD; Morris SK; Sadarangani M; Otley A; Yong E; Mitchell H; Bettinger JA; Top KA;
    Pediatr Transplant; 2023 Dec; 27(8):e14609. PubMed ID: 37746885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella infection following vaccination in a pediatric kidney transplant recipient.
    Bobrowski AE; Muller WJ
    Pediatr Transplant; 2020 Jun; 24(4):e13667. PubMed ID: 32068320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients.
    Kitai IC; King S; Gafni A
    Clin Infect Dis; 1993 Sep; 17(3):441-7. PubMed ID: 8218688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live Vaccine and Varicella Postexposure Prophylaxis in Pediatric Liver Transplant Recipients: A Survey of Practice in Australia and New Zealand.
    Bonett E; Doyle R; Roberts A; Wen SCH
    Pediatr Transplant; 2024 Aug; 28(5):e14833. PubMed ID: 39039719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live virus vaccination of pediatric solid organ transplant candidates within 1 month prior to transplantation: A multicenter experience.
    Rosenthal A; Madigan T; Chen SF; Gans H; Nadimpalli S
    Transpl Infect Dis; 2021 Aug; 23(4):e13667. PubMed ID: 34145665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incomplete Immunity for Varicella and Measles in Pediatric Organ Transplant Candidates. Real World Experience From an Infectious Diseases Pre-Transplantation Clinic.
    Daniels HL; Foster CB; Liu W; Esper F; Sabella C; Gonzalez BE
    Pediatr Transplant; 2024 Nov; 28(7):e14870. PubMed ID: 39370731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated vaccine-induced varicella infection in a kidney transplant recipient.
    Berman MA; Rupp RE
    Am J Transplant; 2023 Nov; 23(11):1806-1810. PubMed ID: 37286085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year Posttransplantation.
    Rezahosseini O; Sørensen SS; Perch M; Ekenberg C; Møller DL; Knudsen AD; Kirkby N; Lundgren J; Lodding IP; Wareham NE; Gustafsson F; Rasmussen A; Nielsen SD
    Clin Infect Dis; 2021 Dec; 73(11):e3733-e3739. PubMed ID: 32564061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunizations following solid-organ transplantation.
    Kumar D
    Curr Opin Infect Dis; 2014 Aug; 27(4):329-35. PubMed ID: 24945614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of a live attenuated varicella vaccine in healthy Indian children aged 9-24 months.
    Ramkissoon A; Coovadia HM; Jugnundan P; Haffejee IE; Meurice F; Vandevoorde D
    S Afr Med J; 1995 Dec; 85(12):1295-8. PubMed ID: 8600589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
    Ozaki T
    Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.